8Z6-14351-44898
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 857 / AZ
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Moderna
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-15
Dose 2 — Moderna
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-08-18
Dose 3 — Moderna
-
2021-11-17
Survey response — 3 months, dose 3MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with relapsed T-cell lymphoma · Healthcare visit (other): Oncology appts & infusions of Belinostat plus all supporting medsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-11-18
-
2022-02-21
Survey response — 6 months, dose 3MedDRA: Abdominal discomfort, Asthenia, Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Abdominal discomfort; lack of energy. All due to chemical infusions to treat relapsed t-cell lymphomaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-20
Survey response — 12 months, dose 3MedDRA: Condition aggravated, Lymphadenopathy, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 10 days after receiving my booster, I experienced enlarged lymph nodes & was diagnosed w/ relapsed T-cell non-Hodgkins lymphoma. I am currently (successfully) being treated with Belinostat infusions, but am reluctant to be boosted again.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-20
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-22
- 2022-08-22
- 2022-08-25
- 2022-08-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2021-08-18 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 10 — 3 months, dose 3
Symptoms: Diagnosed with relapsed T-cell lymphoma
Healthcare visit (other): Oncology appts & infusions of Belinostat plus all supporting meds
Release 11 — 6 months, dose 3
Symptoms: Abdominal discomfort; lack of energy. All due to chemical infusions to treat relapsed t-cell lymphoma
Release 12 — 12 months, dose 3
Symptoms: 10 days after receiving my booster, I experienced enlarged lymph nodes & was diagnosed w/ relapsed T-cell non-Hodgkins lymphoma. I am currently (successfully) being treated with Belinostat infusions, but am reluctant to be boosted again.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release